 | • レポートコード：GIR-105X13888 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、紫斑治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。紫斑治療薬の種類別市場規模（アレルギー性紫斑病、血小板減少性紫斑病）、用途別市場規模（病院用、診療所用、家庭用、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・紫斑治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bristol-Myers Squibb Company、Pfizer Inc、GlaxoSmithKline Plc、Novartis AG、Hovione、Sanofi Winthrop Industrie S.A.、Hoffman-L Roche、Amgen Inc、Grifols Biologicals Inc、Ablynx NV、Biogen Inc、KM Biologics、Lee's Pharmaceutical Holdings Ltd、Omeros Corp、Takeda、Roch ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アレルギー性紫斑病、血小板減少性紫斑病 ・用途別分析2016年-2026年：病院用、診療所用、家庭用、その他 ・紫斑治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・紫斑治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・紫斑治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・紫斑治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・紫斑治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Purpura Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Purpura Therapy Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Purpura Therapy Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Purpura Therapy Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Allergic Purpura
Thrombocytopenic Purpura
Market segment by Application can be divided into
Hospital Use
Clinic Use
Household
Other
The key market players for global Purpura Therapy Drugs market are listed below:
Bristol-Myers Squibb Company
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
Hovione
Sanofi Winthrop Industrie S.A.
Hoffman-L Roche
Amgen Inc
Grifols Biologicals Inc
Ablynx NV
Biogen Inc
KM Biologics
Lee’s Pharmaceutical Holdings Ltd
Omeros Corp
Takeda
Roch
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Purpura Therapy Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Purpura Therapy Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Allergic Purpura
1.2.3 Thrombocytopenic Purpura
1.3 Market Analysis by Application
1.3.1 Overview: Global Purpura Therapy Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Purpura Therapy Drugs Market Size & Forecast
1.4.1 Global Purpura Therapy Drugs Sales in Value (2016-2026))
1.4.2 Global Purpura Therapy Drugs Sales in Volume (2016-2026)
1.4.3 Global Purpura Therapy Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Purpura Therapy Drugs Production Capacity Analysis
1.5.1 Global Purpura Therapy Drugs Total Production Capacity (2016-2026)
1.5.2 Global Purpura Therapy Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Purpura Therapy Drugs Market Drivers
1.6.2 Purpura Therapy Drugs Market Restraints
1.6.3 Purpura Therapy Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb Company
2.1.1 Bristol-Myers Squibb Company Details
2.1.2 Bristol-Myers Squibb Company Major Business
2.1.3 Bristol-Myers Squibb Company Purpura Therapy Drugs Product and Services
2.1.4 Bristol-Myers Squibb Company Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business
2.2.3 Pfizer Inc Purpura Therapy Drugs Product and Services
2.2.4 Pfizer Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business
2.3.3 GlaxoSmithKline Plc Purpura Therapy Drugs Product and Services
2.3.4 GlaxoSmithKline Plc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Purpura Therapy Drugs Product and Services
2.4.4 Novartis AG Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Hovione
2.5.1 Hovione Details
2.5.2 Hovione Major Business
2.5.3 Hovione Purpura Therapy Drugs Product and Services
2.5.4 Hovione Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sanofi Winthrop Industrie S.A.
2.6.1 Sanofi Winthrop Industrie S.A. Details
2.6.2 Sanofi Winthrop Industrie S.A. Major Business
2.6.3 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product and Services
2.6.4 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Hoffman-L Roche
2.7.1 Hoffman-L Roche Details
2.7.2 Hoffman-L Roche Major Business
2.7.3 Hoffman-L Roche Purpura Therapy Drugs Product and Services
2.7.4 Hoffman-L Roche Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Amgen Inc
2.8.1 Amgen Inc Details
2.8.2 Amgen Inc Major Business
2.8.3 Amgen Inc Purpura Therapy Drugs Product and Services
2.8.4 Amgen Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Grifols Biologicals Inc
2.9.1 Grifols Biologicals Inc Details
2.9.2 Grifols Biologicals Inc Major Business
2.9.3 Grifols Biologicals Inc Purpura Therapy Drugs Product and Services
2.9.4 Grifols Biologicals Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Ablynx NV
2.10.1 Ablynx NV Details
2.10.2 Ablynx NV Major Business
2.10.3 Ablynx NV Purpura Therapy Drugs Product and Services
2.10.4 Ablynx NV Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Biogen Inc
2.11.1 Biogen Inc Details
2.11.2 Biogen Inc Major Business
2.11.3 Biogen Inc Purpura Therapy Drugs Product and Services
2.11.4 Biogen Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 KM Biologics
2.12.1 KM Biologics Details
2.12.2 KM Biologics Major Business
2.12.3 KM Biologics Purpura Therapy Drugs Product and Services
2.12.4 KM Biologics Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Lee’s Pharmaceutical Holdings Ltd
2.13.1 Lee’s Pharmaceutical Holdings Ltd Details
2.13.2 Lee’s Pharmaceutical Holdings Ltd Major Business
2.13.3 Lee’s Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product and Services
2.13.4 Lee’s Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Omeros Corp
2.14.1 Omeros Corp Details
2.14.2 Omeros Corp Major Business
2.14.3 Omeros Corp Purpura Therapy Drugs Product and Services
2.14.4 Omeros Corp Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business
2.15.3 Takeda Purpura Therapy Drugs Product and Services
2.15.4 Takeda Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Roch
2.16.1 Roch Details
2.16.2 Roch Major Business
2.16.3 Roch Purpura Therapy Drugs Product and Services
2.16.4 Roch Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Purpura Therapy Drugs Sales by Manufacturer
3.1 Global Purpura Therapy Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Purpura Therapy Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Purpura Therapy Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Purpura Therapy Drugs Manufacturer Market Share
3.4.2 Top 6 Purpura Therapy Drugs Manufacturer Market Share
3.5 Global Purpura Therapy Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Purpura Therapy Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Purpura Therapy Drugs Market Size by Region
4.1.1 Global Purpura Therapy Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Purpura Therapy Drugs Revenue by Region (2016-2026)
4.2 North America Purpura Therapy Drugs Revenue (2016-2026)
4.3 Europe Purpura Therapy Drugs Revenue (2016-2026)
4.4 Asia-Pacific Purpura Therapy Drugs Revenue (2016-2026)
4.5 South America Purpura Therapy Drugs Revenue (2016-2026)
4.6 Middle East and Africa Purpura Therapy Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Purpura Therapy Drugs Sales in Volume by Type (2016-2026)
5.2 Global Purpura Therapy Drugs Revenue by Type (2016-2026)
5.3 Global Purpura Therapy Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Purpura Therapy Drugs Sales in Volume by Application (2016-2026)
6.2 Global Purpura Therapy Drugs Revenue by Application (2016-2026)
6.3 Global Purpura Therapy Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Purpura Therapy Drugs Sales by Type (2016-2026)
7.2 North America Purpura Therapy Drugs Sales by Application (2016-2026)
7.3 North America Purpura Therapy Drugs Market Size by Country
7.3.1 North America Purpura Therapy Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Purpura Therapy Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Purpura Therapy Drugs Sales by Type (2016-2026)
8.2 Europe Purpura Therapy Drugs Sales by Application (2016-2026)
8.3 Europe Purpura Therapy Drugs Market Size by Country
8.3.1 Europe Purpura Therapy Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Purpura Therapy Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Purpura Therapy Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Purpura Therapy Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Purpura Therapy Drugs Market Size by Region
9.3.1 Asia-Pacific Purpura Therapy Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Purpura Therapy Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Purpura Therapy Drugs Sales by Type (2016-2026)
10.2 South America Purpura Therapy Drugs Sales by Application (2016-2026)
10.3 South America Purpura Therapy Drugs Market Size by Country
10.3.1 South America Purpura Therapy Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Purpura Therapy Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Purpura Therapy Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Purpura Therapy Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Purpura Therapy Drugs Market Size by Country
11.3.1 Middle East & Africa Purpura Therapy Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Purpura Therapy Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Purpura Therapy Drugs Typical Distributors
12.3 Purpura Therapy Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Purpura Therapy Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Purpura Therapy Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Company Major Business
Table 5. Bristol-Myers Squibb Company Purpura Therapy Drugs Product and Services
Table 6. Bristol-Myers Squibb Company Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Inc Major Business
Table 9. Pfizer Inc Purpura Therapy Drugs Product and Services
Table 10. Pfizer Inc Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Plc Major Business
Table 13. GlaxoSmithKline Plc Purpura Therapy Drugs Product and Services
Table 14. GlaxoSmithKline Plc Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Purpura Therapy Drugs Product and Services
Table 18. Novartis AG Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hovione Basic Information, Manufacturing Base and Competitors
Table 20. Hovione Major Business
Table 21. Hovione Purpura Therapy Drugs Product and Services
Table 22. Hovione Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sanofi Winthrop Industrie S.A. Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Winthrop Industrie S.A. Major Business
Table 25. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product and Services
Table 26. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hoffman-L Roche Basic Information, Manufacturing Base and Competitors
Table 28. Hoffman-L Roche Major Business
Table 29. Hoffman-L Roche Purpura Therapy Drugs Product and Services
Table 30. Hoffman-L Roche Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 32. Amgen Inc Major Business
Table 33. Amgen Inc Purpura Therapy Drugs Product and Services
Table 34. Amgen Inc Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Grifols Biologicals Inc Basic Information, Manufacturing Base and Competitors
Table 36. Grifols Biologicals Inc Major Business
Table 37. Grifols Biologicals Inc Purpura Therapy Drugs Product and Services
Table 38. Grifols Biologicals Inc Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Ablynx NV Basic Information, Manufacturing Base and Competitors
Table 40. Ablynx NV Major Business
Table 41. Ablynx NV Purpura Therapy Drugs Product and Services
Table 42. Ablynx NV Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Biogen Inc Basic Information, Manufacturing Base and Competitors
Table 44. Biogen Inc Major Business
Table 45. Biogen Inc Purpura Therapy Drugs Product and Services
Table 46. Biogen Inc Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 48. KM Biologics Major Business
Table 49. KM Biologics Purpura Therapy Drugs Product and Services
Table 50. KM Biologics Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Lee's Pharmaceutical Holdings Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Lee's Pharmaceutical Holdings Ltd Major Business
Table 53. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product and Services
Table 54. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Omeros Corp Basic Information, Manufacturing Base and Competitors
Table 56. Omeros Corp Major Business
Table 57. Omeros Corp Purpura Therapy Drugs Product and Services
Table 58. Omeros Corp Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Takeda Basic Information, Manufacturing Base and Competitors
Table 60. Takeda Major Business
Table 61. Takeda Purpura Therapy Drugs Product and Services
Table 62. Takeda Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Roch Basic Information, Manufacturing Base and Competitors
Table 64. Roch Major Business
Table 65. Roch Purpura Therapy Drugs Product and Services
Table 66. Roch Purpura Therapy Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Purpura Therapy Drugs Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 68. Global Purpura Therapy Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Purpura Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Purpura Therapy Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 71. Head Office and Purpura Therapy Drugs Production Site of Key Manufacturer
Table 72. Global Purpura Therapy Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 73. Global Purpura Therapy Drugs Sales by Region (2021-2026) & (K Pcs)
Table 74. Global Purpura Therapy Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Purpura Therapy Drugs Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Purpura Therapy Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 77. Global Purpura Therapy Drugs Sales by Type (2021-2026) & (K Pcs)
Table 78. Global Purpura Therapy Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Purpura Therapy Drugs Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Purpura Therapy Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 81. Global Purpura Therapy Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 82. Global Purpura Therapy Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 83. Global Purpura Therapy Drugs Sales by Application (2021-2026) & (K Pcs)
Table 84. Global Purpura Therapy Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Purpura Therapy Drugs Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Purpura Therapy Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 87. Global Purpura Therapy Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 88. North America Purpura Therapy Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 89. North America Purpura Therapy Drugs Sales by Country (2021-2026) & (K Pcs)
Table 90. North America Purpura Therapy Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Purpura Therapy Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Purpura Therapy Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 93. North America Purpura Therapy Drugs Sales by Type (2021-2026) & (K Pcs)
Table 94. North America Purpura Therapy Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 95. North America Purpura Therapy Drugs Sales by Application (2021-2026) & (K Pcs)
Table 96. Europe Purpura Therapy Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 97. Europe Purpura Therapy Drugs Sales by Country (2021-2026) & (K Pcs)
Table 98. Europe Purpura Therapy Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Purpura Therapy Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Purpura Therapy Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 101. Europe Purpura Therapy Drugs Sales by Type (2021-2026) & (K Pcs)
Table 102. Europe Purpura Therapy Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 103. Europe Purpura Therapy Drugs Sales by Application (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Purpura Therapy Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 105. Asia-Pacific Purpura Therapy Drugs Sales by Region (2021-2026) & (K Pcs)
Table 106. Asia-Pacific Purpura Therapy Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Purpura Therapy Drugs Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Purpura Therapy Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 109. Asia-Pacific Purpura Therapy Drugs Sales by Type (2021-2026) & (K Pcs)
Table 110. Asia-Pacific Purpura Therapy Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 111. Asia-Pacific Purpura Therapy Drugs Sales by Application (2021-2026) & (K Pcs)
Table 112. South America Purpura Therapy Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 113. South America Purpura Therapy Drugs Sales by Country (2021-2026) & (K Pcs)
Table 114. South America Purpura Therapy Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Purpura Therapy Drugs Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Purpura Therapy Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 117. South America Purpura Therapy Drugs Sales by Type (2021-2026) & (K Pcs)
Table 118. South America Purpura Therapy Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 119. South America Purpura Therapy Drugs Sales by Application (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Purpura Therapy Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 121. Middle East & Africa Purpura Therapy Drugs Sales by Country (2021-2026) & (K Pcs)
Table 122. Middle East & Africa Purpura Therapy Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Purpura Therapy Drugs Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Purpura Therapy Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 125. Middle East & Africa Purpura Therapy Drugs Sales by Type (2021-2026) & (K Pcs)
Table 126. Middle East & Africa Purpura Therapy Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 127. Middle East & Africa Purpura Therapy Drugs Sales by Application (2021-2026) & (K Pcs)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Purpura Therapy Drugs Typical Distributors
Table 131. Purpura Therapy Drugs Typical Customers
List of Figures
Figure 1. Purpura Therapy Drugs Picture
Figure 2. Global Purpura Therapy Drugs Sales Market Share by Type in 2020
Figure 3. Allergic Purpura
Figure 4. Thrombocytopenic Purpura
Figure 5. Global Purpura Therapy Drugs Sales Market Share by Application in 2020
Figure 6. Hospital Use
Figure 7. Clinic Use
Figure 8. Household
Figure 9. Other
Figure 10. Global Purpura Therapy Drugs Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Purpura Therapy Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Purpura Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Purpura Therapy Drugs Sales (2016-2026) & (K Pcs)
Figure 32. Global Purpura Therapy Drugs Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Purpura Therapy Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Purpura Therapy Drugs Market Drivers
Figure 35. Purpura Therapy Drugs Market Restraints
Figure 36. Purpura Therapy Drugs Market Trends
Figure 37. Global Purpura Therapy Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Purpura Therapy Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Purpura Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Purpura Therapy Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Purpura Therapy Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Purpura Therapy Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Purpura Therapy Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Purpura Therapy Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Purpura Therapy Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Purpura Therapy Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Purpura Therapy Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Purpura Therapy Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Purpura Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Purpura Therapy Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Purpura Therapy Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Purpura Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Purpura Therapy Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Purpura Therapy Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Purpura Therapy Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Purpura Therapy Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Purpura Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Purpura Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Purpura Therapy Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Purpura Therapy Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Purpura Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Purpura Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Purpura Therapy Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Purpura Therapy Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Purpura Therapy Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Purpura Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Purpura Therapy Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Purpura Therapy Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Purpura Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Purpura Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Purpura Therapy Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Purpura Therapy Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Purpura Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Purpura Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
特発性血小板減少性紫斑病（ITP）治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike. Scope of the Report: This report focus…- 結核薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Tuberculosis Drugs are used to treat tuberculosis.Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked. Scope of the Report: This report focuses on the Tuberculosis Drugs in global market, especially in North America, Europe and Asia-Pacific, South A…
- 性機能障害の薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in th…
- 肝細胞がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The disease originates in the liver unlike the secondary liver cancers which reaches to the liver from other organs of the body. Currently only two drugs NEXAV…
- 急性リンパ性/急性リンパ芽球性白血病薬の世界市場2018-2025 Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes.In 2018, the global Acute Lymphocytic/Lymphoblastic Leukemia Drugs market size was xx million US$ and is forecast to xx million US in 2025, gro…